A Phase 1, Open Label, Ascending Dose Cohort Study of the Pharmacokinetics of Anti-Influenza Hyperimmune Intravenous Immunoglobulin in Healthy Subjects
Clinical trial NCT02037282 · WITHDRAWN
Trial details
- NCT number
- NCT02037282
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-01-03
- Primary completion
- 2014-12-02
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.